The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort studyReport as inadecuate

The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study - Download this document for free, or read online. Document in PDF available to download.

Journal Title:

BMJ Open


Volume 4, Number 12


BMJ Publishing Group: Open Access | 2014-01-01, Pages e006720-e006720

Type of Work:

Article | Final Publisher PDF

Abstract: ObjectiveTo examine the association between exacerbation frequency and mortality following an acute exacerbation of chronic obstructive pulmonary disease AECOPD.DesignCohort study using medical databases.SettingNorthern Denmark.ParticipantsOn 1 January 2005, we identified all patients with prevalent hospital-diagnosed chronic obstructive pulmonary disease COPD who had at least one AECOPD during 1 January 2005 to 31 December 2009. We followed patients from the first AECOPD during this period until death, emigration or 31 December 2009, whichever came first. We flagged all AECOPD events during follow-up and characterised each by the exacerbation frequency 0, 1, 2 or 3+ in the prior 12-month period.Main outcomes and measuresUsing Cox regression, we computed 0–30-day and 31–365-day age-adjusted, sex-adjusted, and comorbidity-adjusted mortality rate ratios MRRs with 95% CIs entering exacerbation frequency as a time-varying exposure.ResultsWe identified 16 647 eligible patients with prevalent COPD, of whom 6664 40% developed an AECOPD and were thus included in the study cohort. The 0–30-day MRRs were 0.97 95% CI 0.80 to 1.18, 0.90 95% CI 0.70 to 1.15 and 1.03 95% CI 0.81 to 1.32 among patients with AECOPD with 1, 2 and 3+ AECOPDs versus no AECOPD within the past 12 months, respectively. The corresponding MRRs were 1.47 95% CI 1.30 to 1.66, 1.89 95% CI 1.59 to 2.25 and 1.59 95% CI 1.23 to 2.05 for days 31–365.ConclusionAmong patients with AECOPD, one or more exacerbations in the previous year were not associated with 30-day mortality but were associated with an increased 31–365-day mortality.

Keywords: Science and Technology - Life Sciences and Biomedicine - Medicine, General and Internal - General and Internal Medicine - OBSTRUCTIVE PULMONARY-DISEASE - HOSPITALIZATION - RISK - EPIDEMIOLOGY - PREDICTORS - OUTCOMES - DEATH -

Author: Sigrun Alba Johannesdottir Schmidt, Martin Berg Johansen, Morten Olsen, Xiao Xu, Joseph M Parker, Nestor A Molfino, Timothy Lash,



Related documents